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To elucidate the mechanism of Apple latent spherical virus (ALSV) movement, various properties of its cell-to-cell movement protein (MP)
were analyzed. ELISA and blot overlay assays demonstrated that the MP bound specifically to ALSV virions and in particular to one of the three
coat proteins (VP25) but not to the other two coat proteins (VP20 and VP24). Mutational analyses have revealed that the MP contains two
domains with independent VP25-binding activity (amino acid residues 1–188 and 189–281). Furthermore, nucleotide-binding experiments
showed that the MP and VP25 bound to single-stranded RNA (ssRNA) and ssDNA without any sequence specificity, but these two proteins did
not bind to double-stranded RNA (dsRNA) and dsDNA. The MP contains three potentially independent single-stranded nucleic acid-binding
domains between amino acid residues 95–188, 189–281 and 277–376. The MP demonstrated cooperative and VP25 demonstrated non-
cooperative binding to ssRNA in gel-retardation analyses. The cooperative RNA binding of the MP became non-cooperative when MP and VP25
were tested together in competition binding experiments, even though a sufficient amount of the MP for fully cooperative RNA binding the MP
was supplied. The roles of the MP and VP25 interactions and nucleic acid binding activities in ALSV movement are discussed.
© 2006 Published by Elsevier Inc.Keywords: Apple latent spherical virus; ALSV; Movement protein; MP; RNA binding; Protein binding; Plant virus movementIntroduction
To establish systemic infections, plant viruses must move
from an infected cell to a neighboring cell (cell-to-cell move-
ment) and enter into the vascular system to move long distances
within the plant (long-distance transport). It is generally
accepted that cell-to-cell movement proteins (MP) encoded by
plant virus genomes modify plasmodesmata in the cell wall,
allowing cell-to-cell movement (Carrington et al., 1996).
Two mechanisms of cell-to-cell movement have been
proposed. In the first type (type 1), the MP interacts with
RNA to form a MP–RNA complex that is able to transport virus
genome to adjacent cells, e.g., Tobacco mosaic virus (TMV)
and Cucumber mosaic virus (CMV). Recent studies have
proposed that TMV moves across plasmodesmata as virus⁎ Corresponding author. Fax: +81 19 621 6107.
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doi:10.1016/j.virol.2006.02.025replication complexes that contain MPs, viral replicase and
genomic RNAs (Kawakami et al., 2004) and that its replicase
protein affects cell-to-cell movement (Knapp et al., 2005).
Additionally, coat protein is essential for the cell-to-cell
movement of CMV, although virion assembly is not required
(Kaplan et al., 1998). In the second type (type 2), mature virions
are transported through viral MP-containing tubules that are
assembled inside the plasmodesmal pore, e.g., Cowpea mosaic
virus (CPMV) and Cauliflower mosaic virus (CaMV). This type
of cell-to-cell movement is called tubule-guided virion
movement (Kasteel et al., 1993; Perbal et al., 1993; Storms et
al., 1990; van Lent et al., 1990; Wieczorek and Sanfaçon, 1993).
The morphology of the virion-containing tubule suggests that
tubule assembly from MP molecules and entrapment of the
virion take place simultaneously at or near the plasma
membrane (Carvalho et al., 2003). It has been shown that the
MP is a component of the tubule structure (van Lent et al., 1990,
1991), the MP is bound specifically to CPMV virions and the
MP engages in self interactions (Carvalho et al., 2003).
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to have the ability to bind RNA because the MP directly
transfers virus genomes or viral transcripts to adjacent cells.
However, the MPs of CaMV and CPMV that belong to the
type 2 class can also bind RNA (Citovsky et al., 1991;
Carvalho et al., 2004). Additionally, viruses that belong to the
type 1 class can sometimes form tubules on the surface of
infected protoplasts (Canto and Palukaitis, 1999). One
possibility is that both mechanisms of movement were used
by the same virus and that the viruses exhibit different
mechanisms in different hosts or tissues (Nurkiyanova et al.,
2001).
Apple latent spherical virus (ALSV) is a member of the
genus Cheravirus and is related closely to the genus Comovirus
in which CPMV is the type species (Fauquet et al., 2005; Li et
al., 2000). ALSV capsids of 25 nm in diameter are assembled
from three species of capsid proteins (VP25, VP20 and VP24)
encapsidating two ssRNA species (RNA1 and RNA2). RNA1
has a single open reading frame encoding a polypeptide of 243K
that contains the protease cofactor, the NTP-binding helicase,
the cystein protease and the RNA polymerase. RNA2 encodes a
polypeptide of 108K that is processed into the MP and the three
CPs. Electron micrographs of ultrathin sections of ALSV-
infected C. quinoa show that tubular structures containing virusFig. 1. Genomic organization of ALSV RNA2 and summary of ALSV MP deletion m
MP that are represented in each MP deletion derivative are illustrated by the gray bars
the MP sequence have the potential to interact with VP25 and ssRNA, respectively.particles traverse the cell wall and are localized in modified
plasmodesmata similar to tubules observed in CPMV-infected
plants (Yoshikawa et al., in press). Therefore, ALSV is thought
to spread from cell-to-cell as virus particles through tubular
structures.
In order to gain insight into the cell-to-cell movement of the
ALSV, we investigated the affinity of the MP for ALSV virions
and for the three individual viral coat proteins (VP25, VP20 and
VP24) comprising the virion, and we analyzed the nucleotide
binding properties of the MP and the VP25 which bound
specifically to the MP in UV cross-linking and gel-retardation
analyses.
Results
Expression and purification of proteins from Escherichia
coli
To study the interaction between the ALSV MP and the
homologous virion, the MP was expressed in E. coli. Truncated
forms of the MP and the wild-type VP25 were also expressed in
E. coli to investigate the nucleotide binding properties of the
MP and the VP25. All of the expressed proteins (Fig. 1) were
purified as described in Materials and methods. Refolding of theutants and their ability to bind VP25 and ssRNA. The regions of the wild-type
. The VP25-binding domains A and B and ssRNA-binding domains A–C within
Fig. 2. Analysis of binding between ALSVMP and ALSV virions using ELISA.
The absorbance values represent averages of three independent experiments.
The wells of microtiter plate were coated with ALSV virion (ALSV) using the
indicated amount (3 μg and 6 μg). The coated wells were probed with the MP
(MP in 150 in PBS) or PBS buffer (non-MP in PBS buffer). BSA was used as
blocking regent, and the absorbance values of BSA bars were low (BSA,
Abs405 = below 0.05; gray and open bars).
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water prior to use. All of the expressed proteins remained
soluble after removing the urea.
Analysis of binding of ALSV MP to homologous virion
The ALSV MP expressed from E. coli was used in ELISA
analyses to evaluate binding to ALSV virions (Fig. 2). TheFig. 3. Gel blot overlay assays of the three coat proteins of ALSV probed with the
following samples: lane 1, BSA; lane 2, ALSVMP; lane 3, ALSV virion; lane 4, TMV
(non-probe). MP was visualized with anti-MP primary antibody and anti-rabbit, AP-
lane 1, Trx-tag; lane 2, ALSVMP; lane 3, ALSV virion; lane 4, VP25 expressed from
Trx tag alone (Trx probe). The Trx tag was visualized using the anti-His primary antib
the following samples: lane 1, BSA; lane 2, ALSV MP; lane 3, VP25 expressed from
MP-M, Trx-MP-C, Trx-MP-N100, Trx-MP-NC, Trx-MP-CN and Trx-MP-C100 pr
visualized with anti-His primary antibody and anti-mouse, AP-linked secondary antwells of microtiter plates were coated with ALSV virions and
then incubated with PBS containing the MP (Fig. 2, MP in
150 μl of PBS, gray bar) or PBS lacking the MP (Fig. 2, non-
MP in PBS, open bar). The MP binding to ALSV virion was
detected using anti-MP and anti-rabbit, AP-linked antibodies.
BSAwas used as a blocking agent because the MP did not show
binding to the BSA (Abs405 = below 0.05; Fig. 2, BSA). High
absorbance was detected using 3 μg of the ALSV virions
(Abs405 = approximately 0.75; Fig. 2, ALSV, 3 μg, gray bar),
and the absorbance increased as the concentration of the ALSV
virions increased (Abs405 = approximately 1.05; Fig. 2, ALSV,
6 μg, gray bar). Conversely, when incubated with PBS lacking
the MP, the 3 μg and 6 μg ALSV virion had the low absorbance
values (Abs405 = approximately 0.1, Fig. 2, ALSV, 3 μg and
6 μg, open bars). These results suggest that the ALSVMP binds
to the homologous virion.
Analyses of MP binding to the three individual viral coat
proteins
To further identify the binding specificity of the ALSV MP
to the individual coat proteins forming the ALSV virion (VP25,
VP20 and VP24), we tested the affinity of the MP for each
protein in gel blot overlay assays using the same conditions that
revealed that the CPMV MP bound specifically to large CPMV
but not to the small coat proteins (Carvalho et al., 2003). The
VP25, VP20 and VP24 proteins from purified ALSV virions
were separated by SDS PAGE and blotted onto membranes that
were incubated with the ALSV MP. The MP that bound to the
coat proteins was detected using the anti-MP and anti-rabbit,
AP-linked antibodies. In a sample containing separated proteins
from ALSV virions, the expected position for VP25 showed a
positive signal, suggesting that the MP had bound to VP25,full-length and truncated forms of ALSV MP. (A) Overlay blots containing the
virions. The blots were probed with the MP (MP probe) and buffer lacking MP
linked secondary antibody. (B) Overlay blots containing the following samples:
E. coli. The blots were probed by the MP fused to a Trx tag (Trx-MP probe) and
ody and anti-mouse, AP-linked secondary antibody. (C) Overlay blots containing
E. coli. The blots were probed with truncated forms of the MP (Trx-MP-N, Trx-
obes; Fig. 1) to analyze VP25-binding domains of the MP. The probes were
ibody.
Fig. 4. RNA-binding analysis of ALSVMP and VP25 by UV cross-linking. The
top panels show SDS PAGE of full-length and truncated forms of ALSVMP and
full-length VP25. The polyacrylamide gels were stained with Coomassie blue
(SDS PAGE). The bottom panels show the ability of the proteins to bind ssRNA
(UV cross-link). (A) The ssRNA-binding ability of the MP and the VP25. +/−
Indicates presence/absence of ssRNA, the MP or the VP25. ‘a’ indicates that
VP25 was added to mixture containing ssRNA and the MP after 30 min. ‘b’
indicates that the MP was added to mixture containing ssRNA and the VP25
after 30 min. (B) Characterization of ssRNA-binding domains of the MP. Trx in
front of the name of the MP deletion mutants indicates that the proteins are fused
to Trx tags containing thioredoxin, histidine and S-protein tags at the N-terminal
ends.
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MP probe, lane 3). We confirmed that VP25 did not show a
signal when the treatment buffer lacks the MP (Fig. 3A, non-
probe, lane 3), and the MP was not detected to bind BSA and
TMV coat protein samples (Fig. 3A, MP probe, lane 1 and lane
4). These results suggested that in this assay the MP binds
specifically to VP25 of purified ALSV virion, but not to the
other coat proteins (VP20 and VP24).
To elucidate the VP25-binding domains of the MP, truncated
MPs (Fig. 1) were also used as probes in gel blot overlay assays.
The antibody against the MP was generated against a peptide
consisting of the 21 C-terminal amino acids of the MP
(Yoshikawa et al., in press) and could not detect the C-
terminally truncated MPs. Additionally, it has previously been
reported that certain deletion proteins are unable to adopt the
correct conformation after denaturation and refolding if they are
not fused to other proteins (Citovsky et al., 1992). Therefore,
the mutants were fused at their N-terminal ends to the Trx tag
(containing tioredoxin, histidine and S-protein tags), and their
binding to VP25 was detected using a His-tag monoclonal
primary antibody (Penta-His-Antibody; QIAGEN) and an anti-
mouse, AP-linked secondary antibody (cell signaling technol-
ogy). The Trx tag alone did not bind VP25, but the MP fused to
the Trx tag (Trx-MP) bound to VP25 (Fig. 3B, Trx probe, lane 3
and Trx-MP probe, lane 3). These results suggest that Trx-MP
can specifically bind to VP25 as in the case of the non-fused
MP. Additionally, the Trx-MP also bound VP25 from E. coli
(Fig. 3B, Trx-MP). Hereafter, we used VP25 expressed from E.
coli and the MP mutants fused to Trx tags to elucidate the VP25-
binding domains of the MP. The MP mutants Trx-MP-N (amino
acids 1–188), Trx-MP-M (amino acids 95–281) and Trx-MP-C
(amino acids 189–376) each had VP25-binding ability (Fig. 1
and Fig. 3C). To further analyze the VP25-binding domains of
Trx-MP-N, Trx-MP-M and Trx-MP-C, we produced mutants
Trx-MP-N100 (amino acids 1–100), Trx-MP-NC (amino acids
95–188), Trx-MP-CN (amino acids 189–281) and Trx-MP-
C100 (amino acids 277–376) (Fig. 1). Of these mutants, only
the Trx-MP-CN probe showed binding to VP25 (Fig. 3C). The
VP25-binding domain of the Trx-MP-N derivative is not
evident within the amino acid residues of Trx-MP-N100 or
Trx-MP-NC, whereas the VP25-binding domains of Trx-MP-M
and Trx-MP-C are contained within the amino acid residues of
Trx-MP-CN (Fig. 1). These results indicate that amino acid
residues 1–188 and 189–281 function independently as VP25-
binding domains (Fig. 1, VP25-binding domain A and B).
Using the His-tag antibody also allowed us to analyze binding
between the MP molecules in vitro. However, binding between
the MP and Trx-MP or the mutants fused to Trx tags was not
detected in this assay (Fig. 3B, Trx-MP probe, lane 2; Fig. 3C).
Nucleic acid binding analyses of the MP and VP25
ALSVMP and VP25 RNA-binding abilities were assayed by
UV cross-linking analyses using a digoxigenin (DIG)-UTP-
labeled RNA probe, as described by Vaquero et al. (1997).
When mixed with the DIG-labeled RNA, the MP and VP25
each showed positive reaction with anti-DIG Fab fragmentscoupled to alkaline phosphatase, but the proteins did not cross-
react in the absence of the RNA probe (Fig. 4A, lanes 1–4).
These results indicate that the MP and VP25 are competent for
ssRNA binding.
To identify the MP domain that is involved in interaction
with ssRNA, we tested the MP deletion mutants fused to Trx
tags (Trx-MP-N, Trx-MP-M and Trx-MP-C; Fig. 1) in UV
cross-linking analyses. All three mutants showed positive
reactions (Fig. 4B, lanes 1–3), but the Trx tag alone did not
bind ssRNA (Isogai and Yoshikawa, 2005). These results
suggest that the mutants are competent for ssRNA binding and
may be explained if the MP contains at least two independently
active ssRNA-binding domains (1–188 aa and 189–376 aa). In
this case, Trx-MP-N and Trx-MP-C would contain at least one
intact RNA-binding domain. We used another set of MP
deletion mutants (Trx-MP-N100, Trx-MP-NC, Trx-MP-CN and
Trx-MP-C100; Fig. 1) to further analyze MP RNA-binding
ability by the UV cross-linking. The Trx-MP-NC, Trx-MP-CN
Fig. 5. Electrophoretic gel-retardation assay. (A) Gel-retardation electrophoresis assay for ALSVMP and VP25 RNA-binding activity. Increasing amounts of the MP (lanes 2–5) and VP25 (lanes 6–9) were incubated in
10 μl of binding buffer with 5 ng of ssRNA, and the mixtures were electrophoresed in a 1% TAE buffered gel. ‘a’ indicates that the MP and VP25 were added to ssRNA at the same time (lanes 10–12). ‘b’ indicates that
VP25 was added after the MP-bound ssRNA (lanes 13–15). The amount of the MP and VP25 used in the assay is indicated. Protein-free ssRNA position is shown in lane 1. (B) The dependence of RNA-binding activity
of the MP and VP25 on NaCl concentration. The MP (1000 ng) and VP25 (1000 ng) were incubated with 5 ng of ssRNA in 10 μl binding buffer with the indicated concentrations of NaCl. Protein-free ssRNA position is
shown in lanes 1 and 12. The asterisk indicates protein-free RNA from the increase of the NaCl concentration. (C and D) Specificity of the RNA-binding properties of the MP and VP25. The MP (C; 1000 ng) and VP25
(D; 1000 ng) were incubated in 10 μl binding buffer with 5 ng of ssRNA (5′ terminal 1440 nt of the ALSVRNA2) in the absence (C and D, lanes 1 and 2) or presence (C, lanes 3–10; D, lanes 3–6) of the indicated amount
of competitors: ssRNA [heat denatured from Rice black streaked dwarf virus (RBSDV) genomic dsRNA; C, lanes 3 and 4; D, lane 3], dsRNA (RBSDV genome; C, lanes 5 and 6; D, lane 4), ssDNA [heat denatured from
plasmid vector (pBluescriptIIKS+); C, lanes 7 and 8; D, lane 5] and dsDNA plasmid DNA (C, lanes 9 and 10; D, lane 6). The positions designated ‘free RNA’ and ‘well’ indicate the positions of the protein-free RNA and
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ability, but the Trx-MP-N100 mutant did not bind the RNA
(Fig. 4B, lanes 4–7). These results indicate that the MP contains
at least three independent RNA-binding domains: amino acid
residues 95–188, 189–281 and 277–376 (Fig. 1, RNA-binding
domains A, B and C).
Comparative analyses of the nucleotide binding activities of the
MP and VP25
We investigated the RNA-binding properties of ALSV MP
and VP25 by gel-retardation analysis. Five nanograms of RNA
transcripts (the 5′ terminal 1440 nucleotides of the ALSV
RNA2 genome) were incubated with increasing amounts of the
MP or VP25. At 125 ng of the MP, most of the ssRNA migrated
as protein-free RNA (Fig. 5A, lanes 1 and 2), but when the
amount of the MP was increased (250 ng or more), the protein-
free RNA signals disappeared (Fig. 5A, lanes 3–5), indicating
that the ssRNA formed a complex with the MP and the complex
barely entered the gel matrix from the well of the agarose gel.
The absence of intermediate bands representing a few protein
molecules bound to ssRNA is characteristic of cooperative
protein binding in a ribonucleoprotein complex (Citovsky et al.,
1990; Lohman et al., 1986). However, the MP–RNA complexes
that could not enter the gel did not show the reaction signals
because the complexes were hardly electroblotted onto nylon
membrane through the base of the gel well (Herranz and Pallás,
2004; Isogai and Yoshikawa, 2005). Conversely, the VP25
demonstrated an RNA-binding profile that was rather different
from that of the MP (Fig. 5A, lanes 6–9): greater amounts of
VP25 resulted in an increase in the degree of retardation of the
RNA molecules, which migrated more slowly than the protein-
free RNA molecules. Although VP25 retarded the mobility of
the RNA, RNA binding of VP25 was apparently not
cooperative (non-cooperative binding).
We analyzed the dependence of the MP and VP25 RNA
binding on electrostatic interaction by increasing the NaCl
concentration of the incubation mixtures (Fig. 5B). Protein-free
RNAwas detected when the NaCl concentration was increased
up to one molar (Fig. 5B, lane 6), suggesting that electrostatic
interaction is involved in the MP RNA-binding activity
(Carvalho et al., 2004; Gomez and Pallas, 2001). In contrast,
a protein-free RNA molecule was not observed in the VP25
samples, even when 1 M NaCl was added to the incubation
mixture (Fig. 5B, lanes 7–11). Interestingly, as the concentra-
tion of salt increased, the intermediate bands representing
VP25-bound ssRNA decreased in intensity, while the bands
began to appear in the wells of these lanes (Fig. 5B, lanes 7–11).
However, the reason has not yet been revealed.
The RNA-binding specificities of the MP and VP25 were
investigated by gel-retardation competition experiments (Figs.
5C and D, respectively). Competition binding assays were
performed by incubation of the ALSV ssRNA and competitor
nucleic acids with the MP or VP25. When ssRNA from
denatured dsRNA of Rice black streaked dwarf virus (RBSDV;
Isogai et al., 1995) genome and ssDNA from denatured
linearized dsDNA of a bacterial vector (pBluscriptIIKS+)were incubated with the MP and VP25, the competitors were
able to compete efficiently with the ALSV RNA for binding to
the proteins (Figs. 5C, lanes 3, 4, 7 and 8, and D, lanes 3 and 5).
The results show that the MP and VP25 bind ssRNA and
ssDNA molecules without sequence specificity. On the other
hand, RBSDV genomic dsRNA and linearized dsDNA from the
plasmid vector did not considerably displace the binding of the
ALSV ssRNA (Figs. 5C, lanes 5, 6, 9 and 10, and D, lanes 4 and
6). These results indicate that both the MP and VP25 have a
preference for binding single-stranded nucleic acids and do not
bind double-stranded nucleic acids significantly.
Analyses of protein–RNA complexes formed by ALSV MP and
VP25 in vitro
Although the individual RNA-binding profiles of VP25
(non-cooperative fashion) and the ALSV MP (cooperative
fashion) were distinct from one another, the demonstrated
interactions between the MP and VP25 inspired further
investigation of RNA complex formation in vitro in the
presence of both of these proteins. When 1000 ng of the MP
(an amount sufficient for cooperative protein–RNA binding)
and variable amounts of VP25 were simultaneously added to the
ssRNA in the binding mixture, non-cooperative RNA-binding
profiles were observed, which was similar to adding VP25 alone
(Fig. 5A, lanes 10–12). In contrast, when VP25 was added to
the mixture after the MP had bound cooperatively to the RNA,
most of the RNA remained in the cooperatively bound MP–
RNA complex at the top of the gel, and a small amount of RNA
migrated to the position observed when VP25 was added alone
(Fig. 5A, lanes 13–15), suggesting that VP25 cannot disrupt a
previously formed MP–RNA complex.
In order to analyze whether the order of addition affects the
ability of the MP and VP25 to bind RNA, we used UV cross-
linking analysis. The two proteins were either added to the RNA
simultaneously (Fig. 4A, lane 5) or sequentially, with 30 min
between protein additions (Fig. 4A, lanes 6 and 7). Both of the
proteins could bind the RNA when added to the mixture at the
same time (Fig. 4A, lane 5). Moreover, when the MP was added
to the RNA first, forming a cooperatively bound MP–RNA
complex, the VP25 added later could still bind RNA (Fig. 4A,
lane 6). Similarly, the MP could bind the RNA when added to
the mixture 30 min after VP25 (Fig. 4A, lane 7). These results
suggest that the VP25 does not interfere with the MP RNA
binding and that the cooperative binding of the MP–RNA
complex does not exclude VP25 RNA binding.
Discussion
Cell-to-cell movement of ALSV is characterized by the
transport of mature virions through tubules that are assembled
inside the plasmodesmata (type 2; see Introduction). In ALSV-
infected plants, tubular structures containing the virus particles
are found protruding through the cell walls into the cytoplasm
of adjacent cells (Yoshikawa et al., in press), and it is predicted
that specific interactions of MP with virus particles are
necessary to form the morphology of the virion-containing
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binds to mature virions and that ALSV MP binds to ALSV
virions in preference to TMV virions. In studies of CPMV cell-
to-cell movement, Carvalho et al. (2003) have also demonstrat-
ed that CPMV MP binds specifically to CPMV virions, but not
to virions of the related comoviruses. Taken together, the data
presented here suggest that the binding between MP and virions
could be essential for the movement of virions through tubules.
These results also imply that viral MPs belonging to viruses
employing the type 2 movement mechanism might bind
specifically to and only assist the movement of their
homologous virions.
Recently, many viral MPs have been identified and shown to
have RNA-binding ability (Herranz and Pallás, 2004; Isogai et
al., 2005; Kim et al., 2004). It is reasonable to assume that viral
MPs belonging to the type 1 class have RNA-binding ability to
form complexes with their viral RNA to facilitate cell-to-cell
movement through plasmodesmata. Surprisingly, CPMV MP
which belongs to the type 2 class is also an RNA-binding
protein, and the reason remains to be elucidated (Carvalho et al.,
2004). We report here that ALSVMP also has the ability to bind
single-stranded nucleic acid, and what is more surprising, it
contains at least three independent ssRNA-binding domains. It
appears that the ability to bind single-stranded nucleic acid
therefore may be an important characteristic common to all
plant viral MPs, including those of the type 2 viruses. It is
possible that the RNA-binding properties of the MPs of type 1
and type 2 viruses play a common role. It is generally accepted
that intracellular transport of viral genomes from the site of
replication to plasmodesmata is likely to involve interactions
between the genome and viral MP (Carrington et al., 1996).
Cytoplasm of ALSV and CPMV-infected cells contains
conspicuous inclusions, which are typical cytopathological
structures (membranous vesicles), and in CPMV infection, it
has been proven that the membranous vesicles are sites for viral
RNA replication (CPMV: De Zoeten et al., 1974; Carette et al.,
2000, 2002a, 2002b; ALSV: data not shown). Our previous
studies have showed that ALSV MPs N- and C-terminal
fusions to green fluorescent protein (GFP) accumulate in
peripheral punctuate spots at the cell wall when they are
transiently expressed in epidermal cells, suggesting that ALSV
MP has the ability to move its site of expressing to the
peripheral punctuate spots, probably plasmodesmata (Yoshi-
kawa et al., in press). Additionally, ALSV particles are always
observed near plasmodesmata and within the vacuole, but not
at the membranous vesicles. Thus, with respect to RNA-
binding and localization properties, ALSV MP might also have
a role in the transfer of viral RNA to virion assembly sites,
probably at or near the plasmodesmata. Alternatively, in
viruses classified into the type 2 movement group, both type 1
and type 2 movement mechanisms may co-exist and the host
or tissue type may determine the mechanisms used by the virus
(Nurkiyanova et al., 2001). In our previous studies, we have
observed green fluorescent protein to move from GFP
expressing cells into the surrounding cells when GFP was
co-expressed with ALSV MP in the leaf epidermis of
Nicotiana tabacum (Yoshikawa et al., in press). In contrast,GFP cell-to-cell movement is rare when GFP was singly
expressed. It has been suggested that the MP facilitates
transport of GFP as well as its own cell-to-cell movement since
ALSV MP is effective beyond the cells immediately
surrounding the expressing cells. Thus, the MP could transfer
viral RNA to the adjacent cells if MP-binding viral RNA
sustained the ability to move from cell-to-cell.
We demonstrated that VP25 as well as the MP have the
ability to bind single-stranded nucleic acids without any
sequence specificity. However, there is a difference between
MP and VP25: MP binds ssRNA cooperatively, whereas VP25
binds ssRNA non-cooperatively. Surprisingly, the MP cooper-
ative RNA binding changes to non-cooperative when VP25 is
added simultaneously with MP, even when the amount of the
MP added was sufficient for cooperative RNA binding in the
absence of VP25. In this paper, we show the direct interaction
between the MP and VP25. It is conceivable that the ALSV
VP25 could alter the MP conformation and change the MP
RNA-binding property into a non-cooperative binding but that
VP25 could not alter previously in existing MP–RNA
cooperatively bound complexes (Fig. 5A). It has been
demonstrated that, for the cell-to-cell movement of Cucumber
mosaic virus (CMV), both its MP (3a protein) and CP are
required, although the assembly of virus particles is not required
for viral movement (Suzuki et al., 1991; Schmitz and Rao,
1998; Canto et al., 1997). The 3a protein binds CMV RNAs
cooperatively and forms the 3a–RNA complex. However, the
complex is not infectious in plants and not translatable in vitro
(Kim et al., 2004). It was speculated that the CP might have a
role in altering the conformation of the 3a protein (Ryabov et al.,
1999; Kim et al., 2004). Thus, it is possible that the interactions
between VP25 and the MP could be involved in complex
formation with the viral RNAs. Future studies should allow us
to elucidate the role played in interaction between the MP and
VP25 in viral infection.
Materials and methods
Generation and expression of cDNA clones
Wild-type and mutated ALSV MP and wild-type VP25
genes (Fig. 1) were amplified by PCR from a plasmid
containing the ALSV infectious cDNA clone (pEALSR2: Li
et al., 2004) using the primers as shown in Table 1. PCR-
amplified products were inserted into the pET-3a and pET-32a
bacterial expression vectors (Novagen). To express the full-
length and deletion mutants of the MP and VP25 (Fig. 1), each
plasmid was transfected into E. coli strain BL21(DE3)pLysS
and expressed as indicated in the manufacturer's instructions
(Novagen). The cells were harvested and lysed by sonication for
10 min on ice in suspension buffer (50 mM Tris–HCl, pH 8.0,
2 mM EDTA). Proteins expressed from pET-32a constructs
contained protein tags (Trx tags; thioredoxin tag, histidine tag
and S-protein tag) at their N-terminal ends, whereas proteins
expressed from pET-3a constructs were non-fused proteins. All
of the expressed proteins in this paper (Fig. 1) formed insoluble
aggregates and were separated from the soluble bacterial protein
Table 1
Primers used in PCR amplification
cDNA clone (expressed protein) Primers (5′–3′) Vector Cloning site
pET-MP + GAATTCCATATGGCTTTGAGCCAATTAGG pET3a NdeI
(MP) − GCGGATCCTCACTGACCTTCTAGCAGATTTGG pET32a BamHI
pET-trx-MP + CTAGCCATGGCTTTTGAGCCAATTAGG pET32a NcoI
(Trx-MP) − GCGGATCCTCACTGACCTTCTAGCAGATTTGG pET32a BamHI
pET-Trx-MP-N + CTAGCCATGGCTTTTGAGCCAATTAGG pET32a NcoI
(Trx-MP-N) − GCGGATCCTTAACATTTATCTCGCCCAAGATC pET32a BamHI
pET-Trx-MP-M + CATGCCATGGTCAAGGATCAAGTGGTGCG pET32a NcoI
(Trx-MP-M) − GCGGATCCTTAAGCATTAAGAAGATTCTGACCA pET32a BamHI
pET-Trx-MP-C + CATGCCATGGATCTCATCTCCTTACCGCT pET32a NcoI
(Trx-MP-C) − GCGGATCCTCACTGACCTTCTAGCAGATTTGG pET32a BamHI
pET-Trx-MP-N100 + CTAGCCATGGCTTTTGAGCCAATTAGG pET32a NcoI
(Trx-MP-N100) − GCGGATCCCTACACTTGATCCTTGACGGACA pET32a BamHI
pET-Trx-MP-NC + CATGCCATGGTCAAGGATCAAGTGGTGCG pET32a NcoI
(Trx-MP-NC) − GCGGATCCTTAACATTTATCTCGCCCAAGATC pET32a BamHI
pET-Trx-MP-CN + CATGCCATGGATCTCATCTCCTTACCGCT pET32a NcoI
(Trx-MP-CN) − GCGGATCCTTAAGCATTAAGAAGATTCTGACCA pET32a BamHI
pET-Trx-MP-C100 + CATGCCATGGCGAATCTTCTTAATGCTATTGAGAAA pET32a NcoI
(Trx-MP-C100) − GCGGATCCTCACTGACCTTCTAGCAGATTTGG pET32a BamHI
pET-VP25 + GAATTCCATATGGGCCCTGATTTCACAAAGATT pET32a NdeI
(VP25) − GCGGATCCTCACTGTCCTATATTATAGAATGTA pET32a BamHI
+: sense primer; −: antisense primer.
Engineered restriction sites are represented in bold.
Start and stop codons are underlined.
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contained protein tags (Trx; thioredoxin tag, histidine tag and S-
protein tag) at their N-terminal ends. The proteins having Trx
tags were solubilized in suspension buffer (20 mM Na2PO4 pH
7.4, 0.5 M NaCl, 10 mM imidazole) containing 8 M urea and
purified using His-Bind resin (Novagen), as indicated in the
manufacturer's instructions. Alternatively, the wild-type MP
and the wild-type VP25 expressed from pET-3a constructs were
non-fused proteins. The insoluble aggregates of the proteins
lacking Trx tags were washed four times with TE to remove
bacterial host protein and were then suspended in 8 M urea
solution (20 mM Na2PO4 pH 7.4, 0.5 M NaCl, 8 M urea).
ELISA for protein-binding assay
The ALSV MP expressed from E. coli was analyzed for
binding to the homologous virions in ELISA as described by
Carvalho et al. (2003). ELISA plates (96-well; greiner) were
coated with purified ALSV particles in 150 μl of coating buffer
(0.05 M sodium carbonate, pH 9.6) at 4 °C overnight. After
rinsing the plates five times with 200 μl of TPBS (0.27 M
NaCl, 16.2 mM Na2PO4, 5.4 mM KCl, 2.94 mM KH2PO4,
0.05% Tween 20, pH 7.4), the wells were blocked with 200 μl
of TPBS containing 5% BSA for 1 h at room temperature. The
plates were washed 5 times with 200 μl of TPBS and then
incubated with 10 ng of the MP in 150 μl of TPBS containing
1% BSA for 90 min at room temperature. The plates were
rinsed 5 times with 200 μl of TPBS and incubated with anti-
MP antibody (Yoshikawa et al., in press) at 37 °C for 60 min.
After washing the plate 5 times with TPBS, the wells were
incubated with 150 μl of anti-rabbit, AP-linked antibody (cell
signaling technology). The wells were then rinsed 5 times withTPBS and 150 μl substrate buffer (0.1 M diethanolamine
buffer, pH 9.6 containing 0.67 mg/ml p-nitrophenyl phos-
phate). Reactions were quantified by reading the absorbance at
405 nm using a microplate reader (Bio-Rad model 550).
Gel blot overlay assay
The ALSV MP expressed from E. coli was analyzed for
binding to the three individual viral coat proteins by gel blot
overlay assay as described by Carvalho et al. (2003). Proteins
were separated by Laemmli's polyacrylamide gel electropho-
resis (1970) and electroblotted onto a PVDF membrane
(Immobilon-P; Millipore). The membrane was washed twice
in denaturing buffer (6 M guanidine hydrochloride, 2 mM
EDTA, 50 mM DTT, 50 mM Tris–HCl, pH 8.3) for 10 min at
room temperature. The proteins were slowly renatured in
serially diluted renaturation buffer (10 mM Tris–HCl, pH 7.4,
150 mM NaCl, 2 mM EDTA, 2 mM DTT and 0.1% NP-40)
containing 4, 3, 2, 1 and 0 M guanidine hydrochloride each
for 10 min at 4 °C for each step. The membranes were
blocked with renaturation buffer containing 10% non-fat dry
milk and 5% glycerol. The blot was incubated with 10 μg/ml
of a probe protein in renaturation buffer containing 10% non-
fat dry milk and 5% glycerol for 90 min at room temperature.
After washing five times with washing buffer, the membrane
was incubated with the MP antibody at 4 °C overnight. The
membrane was then washed five times for 5 min with
washing buffer. The membrane was incubated with anti-
rabbit, AP-linked antibody (cell signaling technology) for
60 min at room temperature and washed four times for 5 min
with washing buffer. Antibody binding was detected using a
BCIP/NBT chromogenic substrate (Sambrook et al., 1989).
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The RNA-binding ability of ALSV MP and VP25 was
assayed by UV cross-linking analysis using a digoxigenin-UTP-
labeled RNA probe as described by Vaquero et al. (1997). The
purified proteins were incubated with 5 ng of a DIG-labeled
actin RNA probe (588 nt; Novagen) in 10 μl of binding buffer
(10 mM Tris pH 8.0, 50 mMNaCl, 1 mM EDTA, 10% glycerol)
at 4 °C for 30 min. The reaction mixtures were irradiated with
1.0 J/cm2 of UV light (BLX-254; BIO-LINK) and treated with
0.5 μg of RNase A at 37 °C for 15 min. Samples were analyzed
by SDS PAGE (Laemmli, 1970). The gel was electroblotted
onto PVDF membrane (Immobilon-P; Millipore) for detection
of the proteins using the DIG-labeled RNA with the
digoxigenin-AP Fab fragments (Roche Applied Science). The
chemiluminescent reaction was developed using CDP-Star
(Roche Applied Science), and the membranes were exposed to
X-ray film.
Gel-retardation analysis
Five nanograms of ssRNAwas mixed with varying amounts
of purified proteins in 10 μl of binding buffer (10 mM Tris–HCl
pH 8.0, 50 mM NaCl, 1 mM EDTA, 10% glycerol) at 4 °C for
30 min (Isogai and Yoshikawa, 2005). After incubation, the
mixtures were subjected to electrophoresis in 1% TAE (40 mM
Tris–acetate, 1 mM EDTA, pH 8.0) agarose. The gel was
electroblotted onto nylon membrane (Hybond N+; Amersham).
The ssRNAwas fixed to the membranes with 0.25 J/cm2 of UV
light (BLX-264; BIO-LINK). The electrophoretic retardation of
the RNAs was visualized using a complementary DIG-labeled
riboprobe and the digoxigenin-AP Fab fragments (Roche
Applied Science). The chemiluminescent reaction was devel-
oped using CDP-Star (Roche Applied Science), and the
membranes were exposed to X-ray film.
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